Media Advisory - Atrium Innovations to Host Analyst/Investor Meeting in Montreal on November 20
MONTREAL, Oct. 15, 2013 /CNW Telbec/ - Atrium Innovations ("the Company") will be hosting an analyst/institutional investor lunch meeting on November 20, 2013 in Montreal. During this meeting, several key executives of the Company will make short presentations followed by an informal session for questions.
The event will be hosted from 11:45 a.m. to 3:00 p.m. at the Centre Sheraton Hotel, 1201 René-Lévesque Blvd. West, Montreal H3B 2L7.
Attendance is limited to institutional investors and analysts.
|12:00-2:00 p.m.||Formal presentations by:|
Pierre Fitzgibbon, President & CEO
Don Allen, Global Supply Chain & Technical Operations
Kyle Bliffert, North American Head of HCP
Paul Hannema, European Head of HCP
Brian Ray, North American Head of HFS, DTC and CMO
Karen Ruettgers, Worldwide Head of Wobenzym®
|2:00-3:00 p.m.||Informal questions session|
About Atrium Innovations
Atrium Innovations Inc. (TSX: ATB) is a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products which are distributed in more than 35 countries. The Company owns healthcare practitioner and specialized retail product brands that are at the forefront of science, innovation and education. Atrium has over 1,100 employees and operates seven manufacturing facilities complying with current Good Manufacturing Practices. Additional information is available at www.atrium-innovations.com.
SOURCE Atrium Innovations Inc.For further information:
Please confirm your presence:
MaisonBrison Communications Inc.
Tel.: 514 731-0000, ext. 237